The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers
暂无分享,去创建一个
Francesca Buttini | Alessandra Rossi | Stavroula Rozou | Varvara Zoumpliou | Dimitrios M Rekkas | D. Rekkas | F. Buttini | S. Rozou | A. Rossi | Varvara Zoumpliou
[1] F. Buttini,et al. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler® in Comparison with Diskus® and Turbohaler® Dry Powder Inhalers , 2016, Journal of aerosol medicine and pulmonary drug delivery.
[2] Maria E Donawa. The evolving process of European combination product review, Part II. , 2008, Medical device technology.
[3] Miryam Barad,et al. Design of Experiments (DOE) , 2018 .
[4] Francesco Polese,et al. A Brief Review of Systems Theories and Their Managerial Applications , 2010 .
[5] A. Ralph,et al. Optimizing aerosolization of a high-dose L-arginine powder for pulmonary delivery , 2015 .
[6] J. M. Juran. Making real change: Building and applying knowledge for improvement , 1993 .
[7] John E. Mills,et al. Design of experiments in pharmaceutical process research and development , 2004 .
[8] R. Ambrus,et al. Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach , 2016, Drug design, development and therapy.
[9] Marcos Llusa,et al. Low-dose capsule filling of inhalation products: critical material attributes and process parameters. , 2014, International journal of pharmaceutics.
[10] Jukka Rantanen,et al. Raman spectroscopy in pharmaceutical product design. , 2015, Advanced drug delivery reviews.
[11] Abhishek Singh,et al. Spray drying formulation of amorphous solid dispersions. , 2016, Advanced drug delivery reviews.
[12] Evdokia Korakianiti,et al. Statistical Thinking and Knowledge Management for Quality-Driven Design and Manufacturing in Pharmaceuticals , 2011, Pharmaceutical Research.
[13] P. Colombo,et al. Spray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product construction. , 2014, International journal of pharmaceutics.
[14] P. Colombo,et al. Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[15] Jérôme Mantanus,et al. Design space approach in the optimization of the spray-drying process. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[16] Lisa M. Law,et al. Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes. , 2017, The journal of allergy and clinical immunology. In practice.
[17] H. Frijlink,et al. Dry powder inhalation: past, present and future , 2017, Expert opinion on drug delivery.
[18] H. Smyth,et al. Carrier-free high-dose dry powder inhaler formulation of ibuprofen: Physicochemical characterization and in vitro aerodynamic performance. , 2016, International journal of pharmaceutics.
[19] Joseph Moses Juran. Juran on Quality by Design: The New Steps for Planning Quality into Goods and Services , 1992 .
[20] P. Colombo,et al. Drug Delivery Strategies for Pulmonary Administration of Antibiotics , 2015 .
[21] Y. Heyden,et al. Raman spectroscopy as a process analytical technology (PAT) tool for the in-line monitoring and understanding of a powder blending process. , 2008, Journal of pharmaceutical and biomedical analysis.
[22] Nicholas Moore,et al. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients , 2017, European Respiratory Journal.
[23] Svend Havelund,et al. Quality by design - Spray drying of insulin intended for inhalation. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[24] Nazrul Islam,et al. Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery--a review for multidisciplinary researchers. , 2012, Medical engineering & physics.
[25] Jukka Rantanen,et al. Engineering of an Inhalable DDA/TDB Liposomal Adjuvant: A Quality-by-Design Approach Towards Optimization of the Spray Drying Process , 2013, Pharmaceutical Research.
[26] Neal G. Anderson,et al. Design of Experiments (DoE) and Process Optimization. A Review of Recent Publications , 2015 .
[27] R. Leggett,et al. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™) , 2015, Journal of aerosol medicine and pulmonary drug delivery.
[28] J. Rantanen,et al. Critical Solvent Properties Affecting the Particle Formation Process and Characteristics of Celecoxib-Loaded PLGA Microparticles via Spray-Drying , 2012, Pharmaceutical Research.
[29] H. Chrystyn,et al. NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma , 2014, Expert opinion on drug delivery.
[30] Paolo Colombo,et al. Design of experiments (DoE) in pharmaceutical development , 2017, Drug development and industrial pharmacy.
[31] A H de Boer,et al. A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect? , 2012, Advanced drug delivery reviews.
[32] Paul W. S. Heng,et al. Process Analytical Technology: Application to Particle Sizing in Spray Drying , 2008, AAPS PharmSciTech.
[33] Stavros N. Politis,et al. The Evolution of the Manufacturing Science and the Pharmaceutical Industry , 2011, Pharmaceutical Research.
[34] Edina Pallagi,et al. New aspects of developing a dry powder inhalation formulation applying the quality-by-design approach. , 2016, International journal of pharmaceutics.
[35] G. Box,et al. On the Experimental Attainment of Optimum Conditions , 1951 .
[36] H. Smyth,et al. Implementation of design of experiments approach for the micronization of a drug with a high brittle–ductile transition particle diameter , 2017, Drug development and industrial pharmacy.
[37] Waseem Kaialy,et al. A review of factors affecting electrostatic charging of pharmaceuticals and adhesive mixtures for inhalation. , 2016, International journal of pharmaceutics.
[38] J. Khinast,et al. Development of a design space and predictive statistical model for capsule filling of low-fill-weight inhalation products , 2016, Drug development and industrial pharmacy.
[39] M. Flament,et al. Dry Powder Inhalers: Study of the Parameters Influencing Adhesion and Dispersion of Fluticasone Propionate , 2012, AAPS PharmSciTech.
[40] B. Bergman,et al. Exploring the epistemological origins of Shewhart’s and Deming’s theory of quality: influences from C.I. Lewis’ conceptualistic pragmatism. , 2009 .
[41] D. Ziegler,et al. Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol , 2010, Current medical research and opinion.
[42] Douglas C. Montgomery,et al. Introduction to Statistical Quality Control , 1986 .
[43] Roger Nosal,et al. PQLI Key Topics - Criticality, Design Space, and Control Strategy , 2008, Journal of Pharmaceutical Innovation.
[44] Holger Grohganz,et al. Design of Experiments-Based Monitoring of Critical Quality Attributes for the Spray-Drying Process of Insulin by NIR Spectroscopy , 2012, AAPS PharmSciTech.
[45] G. K. Raju,et al. Understanding Pharmaceutical Quality by Design , 2014, The AAPS Journal.
[46] H. Chrystyn,et al. The Genuair® inhaler: a novel, multidose dry powder inhaler , 2012, International journal of clinical practice.
[47] Svetlana Lyapustina,et al. Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report. , 2010, Journal of aerosol medicine and pulmonary drug delivery.
[48] Amit G Singal,et al. A Primer on Effectiveness and Efficacy Trials , 2014, Clinical and Translational Gastroenterology.
[49] M Hoppentocht,et al. Technological and practical challenges of dry powder inhalers and formulations. , 2014, Advanced drug delivery reviews.
[50] Da-Hong Gao,et al. Optimization of the operating conditions of a lab scale Aljet mill using lactose and sucrose: A technical note , 2008, AAPS PharmSciTech.
[51] Lawrence X. Yu. Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control , 2008, Pharmaceutical Research.
[52] W. A. Shewhart,et al. Economic quality control of manufactured product , 1930 .
[53] R. Price,et al. Defining the Critical Material Attributes of Lactose Monohydrate in Carrier Based Dry Powder Inhaler Formulations Using Artificial Neural Networks , 2014, AAPS PharmSciTech.
[54] F. Lavorini,et al. Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices , 2016, Drugs & Aging.
[55] H. Chrystyn,et al. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. , 2012, Primary care respiratory journal : journal of the General Practice Airways Group.
[56] V. Pokharkar,et al. Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach. , 2014, Pulmonary pharmacology & therapeutics.
[57] R. Ambrus,et al. Effect of polymers for aerolization properties of mannitol-based microcomposites containing meloxicam , 2013 .
[58] Lawrence X. Yu,et al. Applications of process analytical technology to crystallization processes. , 2004, Advanced drug delivery reviews.